Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impaired Intracranial Compliance: A New Hypertension-Mediated Brain Organ Damage?

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2026
Same author

Symptomatic presentation of cancer in patients diagnosed following emergency self-referral and prior general practice consultations.

Postgraduate medicine·2026
Same author

2026 Latin American consensus for the management of patients with hypertension and cardio-renal and metabolic disturbances: endorsed by the Latin American Society of Hypertension, the Iberoamerican Hypertension League, and the World Hypertension League.

Journal of hypertension·2026
Same author

Comparison of Blood Pressure Values and Antihypertensive Medications Used in Non-Afro-Descendant and Afro-Descendant Brazilians with Hypertension.

Arquivos brasileiros de cardiologia·2026
Same author

Hypertension and Intracranial Hypertension Association: A Narrative Review.

Current hypertension reviews·2025
Same author

Missed opportunities for earlier cancer diagnosis within specific pathways to emergency presentation.

Future oncology (London, England)·2025

Related Experiment Videos

[Hypertension in the elderly population].

Cristina Sierra1, Alfonso López-Soto, Antonio Coca

  • 1Unidad de Hipertensión Arterial, Servicio de Medicina Interna, Hospital Clínic, Universidad de Barcelona, Barcelona, España.

Revista Espanola De Geriatria Y Gerontologia
|February 7, 2009
PubMed
Summary
This summary is machine-generated.

Essential hypertension affects over 65% of Spanish adults over 60, increasing cardiovascular disease risk. Antihypertensive treatment benefits elderly patients, but requires individualized geriatric care.

Related Experiment Videos

Area of Science:

  • Gerontology
  • Cardiology
  • Public Health

Context:

  • Essential hypertension prevalence exceeds 65% in Spanish adults over 60.
  • Elevated systolic pressure is a primary driver of hypertension in this demographic.
  • Cardiovascular disease remains the leading cause of death in developed nations.

Purpose:

  • To review the benefits and challenges of antihypertensive treatment in the elderly.
  • To highlight the importance of individualized care for older adults with hypertension.

Summary:

  • Randomized trials confirm antihypertensive treatment efficacy in elderly hypertensive individuals.
  • Managing hypertension in the elderly is complex due to altered pharmacokinetics, comorbidities, and polypharmacy.
  • Recent evidence supports treatment benefits even in the oldest old (>85 years).

Impact:

  • Emphasizes the need for comprehensive geriatric assessment and tailored treatment strategies.
  • Underscores the critical role of managing hypertension to reduce cardiovascular disease burden in aging populations.
  • Informs clinical practice regarding the effective and safe management of high blood pressure in the elderly.